Product Information
ERTAPENEM 1 GRAM VIAL is a generic product labeled by Eugia US LLC, priced at $26.6295 per EA under NDC 55150028209. Its NADAC has been published 172 times since Jun 21, 2023.
FDA first approved this application on Jun 25, 2018. Its Orange Book therapeutic-equivalence code is AP.
Strength
1 g/1
Manufacturer
Eugia US LLCNDC
55150028209
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
ERTAPENEM SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA209133FDA Approved
6/25/2018
TE Code
AP
On Market Since
6/25/2018
Pharmacological Classes
Price Statistics
The NADAC for ERTAPENEM 1 GRAM VIAL has been published 172 times since Jun 21, 2023, and over the history we have for it it has declined 37.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $26.6295 per EA |
|---|---|
| All-time high | $46.9256 (Jul 10, 2024) |
| All-time low | $25.8742 (Jan 21, 2026) |
| 52-week high | $33.0269 |
| 52-week low | $25.8742 |
| Median price | $36.3239 |
| Average price | $36.6350 |
| Largest weekly change | -9.8% (Nov 19, 2025) |
| Weeks tracked | 172 |
| Tracking since | Jun 21, 2023 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eugia US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ertapenem market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Penem Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ERTAPENEM 1 GRAM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for ERTAPENEM 1 GRAM VIAL, manufactured by Eugia US LLC, is $26.6295 per EA (NDC 55150028209), effective Sep 30, 2026.
How has the price of ERTAPENEM 1 GRAM VIAL changed over time?
Over the history we have for it, the NADAC for ERTAPENEM 1 GRAM VIAL has declined 37.2%. It has been tracked across 172 weekly CMS publications since Jun 21, 2023.
What are the highest and lowest recorded NADAC prices for ERTAPENEM 1 GRAM VIAL?
Since Jun 21, 2023, the NADAC for ERTAPENEM 1 GRAM VIAL has ranged from a low of $25.8742 (Jan 21, 2026) to a high of $46.9256 (Jul 10, 2024), with a median of $36.3239 per EA.
Are there cheaper alternatives to ERTAPENEM 1 GRAM VIAL?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ERTAPENEM 1 GRAM VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures ERTAPENEM 1 GRAM VIAL?
ERTAPENEM 1 GRAM VIAL (NDC 55150028209) is labeled by Eugia US LLC, and CMS classifies it as a generic product.